Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Swift Regulatory and Market Strategy for IVD Consumer Product

A well-known IVD consumer product in Europe suddenly became the target of a competitor’s lawsuit, forcing its manufacturer to urgently revise the product’s marketing strategy, packaging, and labeling. Any delay in supplying this product could have led to a significant drop in market share. Given these high stakes, the company sought immediate assistance from Zamann Pharma Support.

 

A comprehensive, risk-based approach was quickly put into action. Experts in regulatory affairs, experienced freelancers specializing in key areas, and lawyers familiar with IVD regulations joined forces under the Zamann umbrella. Within just a few weeks, the entire product strategy was updated, technical documentation was revised, and all regulatory registrations were renewed. This proactive approach ensured manufacturing resumed without disrupting the market, saving the client from potentially major commercial and reputational losses.

Challenges Faced

A detailed GAP analysis in Quality Management Systems is essential for identifying process deficiencies effectively.
  • Legal Pressures: A competitor’s legal actions demanded immediate changes to the product’s presentation, leaving no room for a lengthy review process.
  • Risk of Supply Interruption: Any pause in production or delivery would have eroded the product’s hard-earned market share.
  • Regulatory Complexity: The IVD space has its own set of detailed regulations, and ensuring compliance in record time demanded coordination among multiple specialists.
  • Limited Timeframe: The client needed rapid solutions to avert product shortages and align documentation with fresh requirements imposed by the legal dispute.

Zamann Pharma Support’s Approach

  • Risk-Based Strategy: A focused plan was created, prioritizing critical tasks first. This strategic sequencing enabled work to start immediately on areas with the greatest impact on market supply and compliance.
  • Expert Collaboration: Zamann assembled a team of seasoned regulatory professionals, area-specific freelancers, and legal advisors. Each specialist addressed a particular aspect of the lawsuit’s repercussions—regulatory approvals, documentation updates, and contractual changes.
  • Rapid Documentation Overhaul: The product’s technical documents were reviewed and updated in parallel. New packaging and labeling guidelines were aligned with both legal advice and regulatory standards.
  • Accelerated Regulatory Submissions: Filing updates for registrations took place simultaneously. Close coordination with relevant authorities allowed the product’s status to be approved quickly, averting potential supply chain delays.

Results Achieved

  • Maintenance of Market Share: Due to the swift completion of documentation and regulatory tasks, the client continued supplying the product without interruption.
  • Streamlined Compliance: All necessary updates to the product’s labeling and documentation met legal and regulatory requirements, protecting the company from further legal or regulatory action.
  • Shorter Turnaround: What could typically stretch to a year of work was condensed into just a few weeks. Production and distribution resumed with minimal downtime.
  • Collaborative Efficiency: By unifying lawyers, consultants, and regulatory experts under one umbrella, the client saved time, reduced overhead, and resolved the crisis at an impressive speed.
Laboratory
Regulatory team preparing technical documentation for medical device and IVD EU registration aligned with MDR and IVDR requirements
Services

Medical Devices & IVDs EU Registration

We guide companies through medical device and IVD EU registration by supporting MDR and IVDR requirements, technical documentation, and structured processes for compliant market access.

Read More

Contact Us

Need help? Don't hesitate to get in touch
Zamann pharma support is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

FAQ

Companies activate a rapid, risk-based response plan that prioritizes regulatory and labeling updates first. Then, they coordinate legal, regulatory, and quality experts in parallel workflows. As a result, they maintain product supply while resolving legal and compliance issues.

2. What is the fastest way to update technical documentation and labeling under strict IVD regulatory pressure?

Teams perform simultaneous documentation review and regulatory alignment instead of sequential updates. In addition, they integrate legal requirements directly into packaging and labeling changes. Therefore, companies reduce turnaround time and ensure full compliance at the same time.

3. How do cross-functional expert teams help prevent market loss during urgent regulatory changes in diagnostic products?

Cross-functional teams combine regulatory specialists, legal advisors, and quality experts into one coordinated structure. Moreover, they work in parallel rather than in isolation to speed up decisions. Consequently, companies avoid supply interruption and protect market share during critical regulatory events.